Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagliflozin Tablets Are Taken up in the Body
Sponsor: Boehringer Ingelheim
Summary
The main objective of this trial is to establish the bioequivalence of two different formulations of vicadrostat / empagliflozin in healthy male and female trial participants following oral administration.
Official title: Bioequivalence of Two Different Vicadrostat / Empagliflozin Formulations Following Oral Administration in Healthy Trial Participants (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Trial)
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2026-10-14
Completion Date
2026-12-21
Last Updated
2026-10-15
Healthy Volunteers
Yes
Conditions
Interventions
Vicadrostat
Vicadrostat
Empagliflozin
Empagliflozin
Vicadrostat + empagliflozin
Vicadrostat + empagliflozin combined
Locations (1)
Humanpharmakologisches Zentrum Biberach
Biberach, Germany